Chinas AI Media System Ignores Japanese Politicians Condolences After Coal Mine Disaster Indias Labor Market Under Pressure as Iran Conflict Disrupts Remittances and Trade Trump Administrations PFAS Regulation Reversal Sparks Industry and Health Debate UK Exports to US Slump 25 Following Trumps Liberation Day Tariff Actions Nvidia Data Center Revenue Nearly Doubles as Strong Earnings Report Prompts Stock Decline US Q1 GDP Growth Revised Down to 16 as Consumer Spending Shows Signs of Slowing ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline MTNB Q4 2024 Earnings NarrowerthanExpected Loss Drives Positive Stock Movement PDS Biotechnology Q1 2026 Earnings EPS Beat Highlights Progress Despite PreRevenue Status LYG Q1 2026 Earnings Strong Earnings Beat Despite Stock Decline GETY Q1 2026 Earnings EPS Falls Sharply Below Consensus Stock Slips Safe Pro Group Inc SPAI Q1 2026 Earnings EPS Miss Marks Challenging Quarter for PreRevenue Tech Firm Mercer International MERC Rallies 69 to 104 Testing Key Resistance iRhythm Holdings IRTC Edges Lower Testing Support Levels After Slight Decline Klarna Group KLAR Rallies 4 Approaching Key Resistance Amid Renewed Buyer Interest Oragenics Inc OGEN Edges Higher as Biotech Volatility Persists Standex International SXI Holds Steady Near 271 After Modest Gain Cineverse Corp CNVS Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty KLIC Q1 2026 Earnings EPS Surges Past Estimates as Semiconductor Demand Holds Steady KR Q1 2026 Earnings EPS Beats Estimates Stock Declines 4 Despite Strong Core Performance Thermo Fisher Scientific Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Pullback Coty Q1 2026 Earnings A Narrow EPS Miss Amid Lingering Challenges Pioneer Power Solutions Inc PPSI Q1 2026 Earnings Loss Widens Stock Rises Unexpectedly AI Infrastructure and Energy Basket Outperforms Nvidia A Potential Winning Trade IBKR Q1 2026 Earnings Earnings Miss Expectations Amid Volatile Markets Cabaletta Bio Holds Steady CABA Stock Rises Slightly Amid Biotech Volatility